Roland Rutschmann
Fortuna: 28 M $ al 30/09/2026
Fortuna: 28 M $ al 30/09/2026
Roland Rutschmann currently works at Curatis Holding AG, as Chief Executive Officer & Executive Director from 2024.
Mr. Rutschmann also formerly worked at Actelion Ltd., as Vice President-Strategic Marketing & GM and Orphan Europe SARL, as General Manager from 2009 to 2011.
Mr. Rutschmann received his doctorate degree from the University of Basel.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
23,43 % | 31/12/2025 | 1.245.000 ( 23,43 % ) | 28 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|
| Empresas | Cargo | Fin |
|---|---|---|
Orphan Europe SARL
Orphan Europe SARL Pharmaceuticals: MajorHealth Technology Develops and distributes orphan drugs for the treatment of rare diseases and metabolic disorders | Corporate Officer/Principal | 01/01/2011 |
| ACTELION | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Actelion Ltd.
Actelion Ltd. Pharmaceuticals: MajorHealth Technology Develops, produces and markets pharmaceutical drugs | Health Technology |
University of Basel
University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orphan Europe SARL
Orphan Europe SARL Pharmaceuticals: MajorHealth Technology Develops and distributes orphan drugs for the treatment of rare diseases and metabolic disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.